QTDM and National Disability Insurance Agency [2022] AATA 3826 (15 November 2022)
Division:NATIONAL DISABILITY INSURANCE SCHEME DIVISION
File Number(s): 2021/5384
Re:QTDM
APPLICANT
AndNational Disability Insurance Agency
RESPONDENT
Decision
Tribunal:Member W Frost
Date:15 November 2022
Place:Canberra
The Tribunal affirms the decision under review pursuant to subsection 43(1)(a) of the Administrative Appeals Tribunal Act 1975.
...................[SGD].........................................
Member W Frost
Catchwords
NATIONAL DISABILITY INSURANCE SCHEME – access to scheme – ankylosing spondylitis – inflammatory bowel disease – asthma - whether the applicant satisfies the disability requirements – whether applicant has a disability attributable to an impairment - whether impairments substantially reduced functional capacity to undertake any one or more specified activities specified in s 24(1)(c) – where no functional assessment provided to the Tribunal – totality of available evidence - decision affirmed
Legislation
Administrative Appeals Tribunal Act, ss 35, 43
National Disability Insurance Scheme Act 2013, ss 3, 18, 20, 22, 23, 25, 28, 33, 209
National Disability Insurance Scheme (Becoming a Participant) Rules 2016
Cases
National Disability Insurance Agency v Davis [2022] FCA 1002
Ditchfield and NDIA [2019] AATA 2121
Drake and Minister for Immigration and Ethnic Affairs (No 2) (1979) 2 ALD 634
Madelaine and NDIA [2020] AATA 4025
Mulligan v National Disability Insurance Agency [2015] FCA 544
Howard and National Disability Insurance Agency [2019] AATA 2
HPSC and National Disability Insurance Agency [2021] AATA 727
Schwass and NDIA [2019] AATA 28
Secondary Materials
Access to the NDIS Operational Guideline
REASONS FOR DECISION
Member W Frost
15 November 2022
INTRODUCTION
The Applicant, QTDM, is 42 years old.[1] In April 2021, QTDM applied to become a participant in the National Disability Insurance Scheme (NDIS) due to the effects of her ankylosing spondylitis (AS), which is a form of arthritis, inflammatory bowel disease (IBD) and asthma.[2]
[1] Exhibit 1, pages 2 and 30.
[2] Ibid., pages 28-52. See also Exhibit 3.
In May 2021, a delegate of the Chief Executive Officer (CEO) of the National Disability Insurance Agency (NDIA) determined that QTDM did not meet the access requirements set out in the National Disability Insurance Scheme Act 2013 (NDIS Act).[3]
[3] Ibid., pages 53-57.
QTDM requested an internal review by the NDIA[4] and, in July 2021, another delegate of the CEO confirmed its decision that QTDM did not satisfy the access criteria in either sections 24 (containing the disability requirements) or 25 (containing the early intervention requirements) of the NDIS Act.[5] Pursuant to section 103 of the NDIS Act, in August 2021, QTDM applied to the Administrative Appeals Tribunal (Tribunal) for review of the NDIA’s decision.[6]
[4] Ibid., page 60.
[5] Ibid., pages 6-25.
[6] Ibid., pages 1-5.
Due to the personal nature of the symptoms or effects of QTDM’s impairments, the Tribunal made an order under section 35 of the Administrative Appeals Tribunal Act 1975 prohibiting the publication of her name and any other information tending to reveal QTDM’s identity, including the name of…
Keep reading for free
Create a free CaseChat account to read QTDM and National Disability Insurance Agency and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2022] AATA 3826
- Decision Date
CaseChat Overview and Summary
The primary legal issues before the AAT were whether QTDM satisfied the disability requirements for access to the NDIS as set out in section 24 of the NDIS Act 2013 (Cth). Specifically, the Tribunal was required to determine if QTDM had a disability attributable to one or more impairments, if those impairments were permanent, and if they substantially reduced her functional capacity to undertake specified activities. The NDIA also contended that there was insufficient evidence to conclude that QTDM required the support of the NDIS for her lifetime.
The Tribunal found that QTDM's ankylosing spondylitis (AS) and inflammatory bowel disease (IBD) met the criterion of being a disability attributable to an impairment under section 24(1)(a) of the NDIS Act. However, the Tribunal was not satisfied that QTDM's asthma met this criterion due to a lack of sufficient medical evidence regarding its impact on her daily life. The NDIA had also contended that QTDM's AS was not permanent and that her functional capacity was not substantially reduced. The Tribunal affirmed the NDIA's decision, finding that QTDM did not meet the disability requirements for access to the NDIS at that time.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
The NDIA accepted that QTDM has a disability attributable to her physical impairment of AS and therefore satisfied subsection 24(1)(a) of the NDIS Act, although it submitted that there was insufficient evidence to conclude that QTDM’s asthma and IBD met this criterion. The NDIA further contended that on the available evidence QTDM’s AS could not be considered ‘permanent’ and she could therefore not satisfy subsection 24(1)(b) of the NDIS Act. Additionally, while the NDIA accepted that, due to her AS, QTDM has some reduced functional capacity, it submitted that there was insufficient evidence to demonstrate that QTDM has a substantially reduced functional capacity in one or more of the activities set out under subsection 24(1)(c) of the NDIS Act. Given the above contentions, the NDIA submitted that it could not be found that QTDM requires the support of the NDIA for her lifetime pursuant to subsection 24(1)(e) of the NDIS Act. CONSIDERATIONDoes QTDM have a disability attributable to one or more impairments? The Tribunal must be satisfied that QTDM meets all the requirements specified in subsections 24(1)(a) to (e) of the NDIS Act in order to find that she meets the ‘disability requirements’ for access to the NDIS.[33] [33] Howard and National Disability Insurance Agency [2019] AATA 2 at [25]. The Tribunal is satisfied, and the NDIA did not dispute, that QTDM’s ankylosing spondylitis, or AS, meets the criterion in subsection 24(1)(a) of the NDIS Act, being that she has a disability attributable to this physical impairment. QTDM’s AS causes her to experience, among other things, chronic pain, fatigue and reduced mobility. The Tribunal also accepts, based on the evidence set out above in these reasons, that QTDM’s IBD meets the legislative requirement in subsection 24(1)(a) of the NDIS Act. While the medical documentation did not provide a clear or settled diagnosis in relation to QTDM’s gastrointestinal issues, IBD appeared the most likely diagnosis based on the totality of the evidence, including QTDM’s testimony. QTDM described her impairments as a result of this disability and the Tribunal accepts this evidence for the purpose of subsection 24(1)(a) of the NDIS Act. However, while the Tribunal is satisfied that QTDM has asthma, having regard to all the evidence, the Tribunal was left in a state of uncertainty about its impact on her daily life, including whether it was attributable to one or more impairments. To this end, there was a distinct lack of medical evidence about QTDM’s asthma, with the only identifiable reference being the rheumatologist, Dr Ross’ notation that it ‘[c]ame back as an adult after SARS in 2003’ and that she currently takes asthma medication.[34] While not discounting the effect of this condition, based on the available evidence, the Tribunal finds that QTDM’s asthma is not a disability attributable to one or more impairments as required by subsection 24(1)(a) of the NDIS Act. [34] Exhibit 1, page 26.